Year |
Citation |
Score |
2016 |
Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. Plos One. 11: e0152243. PMID 26998759 DOI: 10.1371/journal.pone.0152243 |
0.817 |
|
2015 |
Liang M, Adisetiyo H, Liu X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. Plos One. 10: e0131232. PMID 26196517 DOI: 10.1371/Journal.Pone.0131232 |
0.841 |
|
2014 |
Yang-Hartwich Y, Soteras MG, Lin ZP, Holmberg J, Sumi N, Craveiro V, Liang M, Romanoff E, Bingham J, Garofalo F, Alvero A, Mor G. p53 protein aggregation promotes platinum resistance in ovarian cancer. Oncogene. 34: 3605-16. PMID 25263447 DOI: 10.1038/onc.2014.296 |
0.302 |
|
2014 |
Liang M, Mulholland DJ. Lipogenic metabolism: a viable target for prostate cancer treatment? Asian Journal of Andrology. 16: 661-3. PMID 24969061 DOI: 10.4103/1008-682X.132947 |
0.422 |
|
2014 |
Adisetiyo H, Liang M, Liao CP, Jeong JH, Cohen MB, Roy-Burman P, Frenkel B. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. Journal of Cellular Physiology. 229: 1170-6. PMID 24752784 DOI: 10.1002/Jcp.24546 |
0.839 |
|
2014 |
Geary LA, Nash KA, Adisetiyo H, Liang M, Liao CP, Jeong JH, Zandi E, Roy-Burman P. CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features. Molecular Cancer Research : McR. 12: 607-21. PMID 24464914 DOI: 10.1158/1541-7786.Mcr-13-0469 |
0.836 |
|
2013 |
Pham LK, Liang M, Adisetiyo HA, Liao CP, Cohen MB, Tahara SM, Frenkel B, Kasahara N, Roy-Burman P. Contextual effect of repression of bone morphogenetic protein activity in prostate cancer. Endocrine-Related Cancer. 20: 861-74. PMID 24042462 DOI: 10.1530/Erc-13-0100 |
0.807 |
|
2013 |
Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, Neamati N, Conway EM, Cheng CY, Nikitin AY, Roy-Burman P. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. Plos One. 8: e69484. PMID 23936028 DOI: 10.1371/Journal.Pone.0069484 |
0.823 |
|
2013 |
Liang M, Adisetiyo HA, Li X, Liu R, Gill PS, Roy-Burman P. Abstract 4087: Androgen receptor splice variants in mouse prostate cancer cell lines: altered distribution in lines derived from castration-resistant tumors relative to those primary tumors. Cancer Research. 73: 4087-4087. DOI: 10.1158/1538-7445.Am2013-4087 |
0.846 |
|
2012 |
Geary L, Adisetiyo H, Liang M, Jeong H, Zandi E, Roy-Burman P. Abstract 1476: Prostate cancer-associated fibroblasts secrete Annexin A1 that facilitates both generation of cancer stem cell-like cells (CSCs) from prostatic malignant epithelial cells and self-renewal/differentiation of CSCs Cancer Research. 72: 1476-1476. DOI: 10.1158/1538-7445.Am2012-1476 |
0.833 |
|
2011 |
Adisetiyo HA, Liang M, Liao C, Aycock-Williams A, Cohen MB, Conway EM, Roy-Burman P. Abstract LB-51: Pten null prostate tumorigenesis and prostate stem cell activity are inhibited by targeted knockout of the Survivin gene Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-51 |
0.841 |
|
2010 |
Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer stem cells and microenvironment in prostate cancer progression. Hormones & Cancer. 1: 297-305. PMID 21761361 DOI: 10.1007/S12672-010-0051-5 |
0.848 |
|
2010 |
Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Research. 70: 7294-303. PMID 20807814 DOI: 10.1158/0008-5472.Can-09-3982 |
0.843 |
|
2010 |
Liao CP, Liang M, Cohen MB, Flesken-Nikitin A, Jeong JH, Nikitin AY, Roy-Burman P. Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Hormones & Cancer. 1: 44-54. PMID 20631921 DOI: 10.1007/S12672-009-0005-Y |
0.81 |
|
Show low-probability matches. |